eyeDNA PDE6B gene therapy

· eyeDNA Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for eyeDNA PDE6B gene therapy, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene [Phase 1, Phase 2]